{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:14:23Z","timestamp":1790421263569,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.mcna.2014.11.005","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T13:03:37Z","timestamp":1424264617000},"page":"295-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Appropriate Prescribing and Important Drug Interactions in Older Adults"],"prefix":"10.1016","volume":"99","author":[{"given":"Jeffrey","family":"Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Paauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.mcna.2014.11.005_bib1","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1001\/jama.2008.892","article-title":"Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States","volume":"300","author":"Qato","year":"2008","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mcna.2014.11.005_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0976-500X.110872","article-title":"Adverse drug reactions in the elderly","volume":"4","author":"Brahma","year":"2013","journal-title":"J\u00a0Pharmacol Pharmacother"},{"issue":"9","key":"10.1016\/j.mcna.2014.11.005_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","article-title":"Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes","volume":"65","author":"Gnjidic","year":"2012","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"13","key":"10.1016\/j.mcna.2014.11.005_bib4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/archinternmed.2010.153","article-title":"Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score","volume":"170","author":"Onder","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2014.11.005_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.287.3.337","article-title":"Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey","volume":"287","author":"Kaufman","year":"2002","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.mcna.2014.11.005_bib6","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1001\/jama.2010.1482","article-title":"Managing medications in clinically complex elders: \u201cThere\u2019s got to be a happy medium.\u201d","volume":"304","author":"Steinman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2014.11.005_bib7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jama.294.6.716","article-title":"Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance","volume":"294","author":"Boyd","year":"2005","journal-title":"JAMA"},{"issue":"27","key":"10.1016\/j.mcna.2014.11.005_bib8","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1056\/NEJMsb042458","article-title":"Potential pitfalls of disease-specific guidelines for patients with multiple conditions","volume":"351","author":"Tinetti","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.mcna.2014.11.005_bib9","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1592\/phco.2005.25.11.1636","article-title":"Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting","volume":"25","author":"Zarowitz","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.mcna.2014.11.005_bib10","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/j.1532-5415.2012.04187.x","article-title":"Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity","volume":"60","author":"American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.mcna.2014.11.005_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11739-014-1124-1","article-title":"Multimorbidity and polypharmacy in the elderly: lessons from REPOSI","volume":"9","author":"Mannucci","year":"2014","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.mcna.2014.11.005_bib12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","article-title":"American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"60","author":"The American Geriatrics Society 2012 Beers Criteria Update Expert Panel","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.mcna.2014.11.005_bib13","unstructured":"HEDIS. Available at: http:\/\/www.ncqa.org\/tabid\/1274\/default.aspx. Accessed October 3, 2014."},{"key":"10.1016\/j.mcna.2014.11.005_bib14","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency hospitalizations for adverse drug events in older Americans","volume":"365","author":"Budnitz","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2014.11.005_bib15","doi-asserted-by":"crossref","first-page":"531S","DOI":"10.1378\/chest.11-2304","article-title":"Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"You","year":"2012","journal-title":"Chest"},{"issue":"13","key":"10.1016\/j.mcna.2014.11.005_bib16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin, or both after myocardial infarction","volume":"347","author":"Hurlen","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2014.11.005_bib17","series-title":"Adherence to long-term therapies","author":"WHO","year":"2003"},{"issue":"4","key":"10.1016\/j.mcna.2014.11.005_bib18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2215\/CJN.07290810","article-title":"Kidney function and long-term medication adherence after myocardial infarction in the elderly","volume":"6","author":"Chang","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.mcna.2014.11.005_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2014.11.005_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.18553\/jmcp.2012.18.7.527","article-title":"Dosing frequency and medication adherence in chronic disease","volume":"18","author":"Coleman","year":"2012","journal-title":"J\u00a0Manag Care Pharm"},{"key":"10.1016\/j.mcna.2014.11.005_bib21","first-page":"814","article-title":"The implications of therapeutic complexity on adherence to cardiovascular medications","volume":"171","author":"Choudhry","year":"2011","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.mcna.2014.11.005_bib22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11606-005-0113-5","article-title":"The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens","volume":"20","author":"Glasheen","year":"2005","journal-title":"J\u00a0Gen Intern Med"},{"issue":"9","key":"10.1016\/j.mcna.2014.11.005_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.279.9.657","article-title":"Acetaminophen and other risk factors for excessive warfarin anticoagulation","volume":"279","author":"Hylek","year":"1998","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.mcna.2014.11.005_bib24","first-page":"1621","article-title":"Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study","volume":"91","author":"Mahe","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.mcna.2014.11.005_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00228-010-0975-2","article-title":"Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial","volume":"67","author":"Zhang","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.mcna.2014.11.005_bib26","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa043903","article-title":"Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis","volume":"354","author":"Centanni","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2014.11.005_bib27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/0091270005276738","article-title":"Dipyridamole bioavailability in subjects with reduced gastric acidity","volume":"45","author":"Derendorf","year":"2005","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.mcna.2014.11.005_bib28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1365-2036.2009.03993.x","article-title":"Systematic review: impaired drug absorption related to the co-administration of antisecretory therapy","volume":"29","author":"Lehner","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.mcna.2014.11.005_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1185\/03007995.2013.772051","article-title":"Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients","volume":"29","author":"Mahabaleshwarkar","year":"2013","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.mcna.2014.11.005_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/clc.22094","article-title":"Pharmacodynamic impacts of proton pump inhibitors on the efficacy of clopidogrel in\u00a0vivo\u2013a systematic review","volume":"36","author":"Chen","year":"2013","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.mcna.2014.11.005_bib31","article-title":"Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction","author":"Depta","year":"2014","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"10.1016\/j.mcna.2014.11.005_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3810\/pgm.2014.05.2772","article-title":"Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling","volume":"126","author":"Johnson","year":"2014","journal-title":"Postgrad Med"},{"issue":"7","key":"10.1016\/j.mcna.2014.11.005_bib33","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.amjmed.2005.02.007","article-title":"Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial","volume":"118","author":"O'Connell","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.mcna.2014.11.005_bib34","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ajg.2011.113","article-title":"Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies","volume":"106","author":"Ngamruengphong","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2014.11.005_bib35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2011.01.007","article-title":"Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies","volume":"124","author":"Yu","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.mcna.2014.11.005_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MED.0000000000000031","article-title":"Proton pump inhibitor therapy and potential long-term harm","volume":"21","author":"Corleto","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"10.1016\/j.mcna.2014.11.005_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1056\/NEJMcp1113996","article-title":"Clinical practice: vitamin B12 deficiency","volume":"368","author":"Stabler","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2014.11.005_bib38","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2014.02.010","article-title":"A\u00a0clinician\u2019s guide to statin drug-drug interactions","volume":"8","author":"Kellick","year":"2014","journal-title":"J\u00a0Clin Lipidol"},{"issue":"23","key":"10.1016\/j.mcna.2014.11.005_bib39","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1001\/jama.2013.282426","article-title":"Calcium-channel blocker\u2013clarithromycin drug interactions and acute kidney injury","volume":"310","author":"Gandhi","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mcna.2014.11.005_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1503\/cmaj.100702","article-title":"The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers","volume":"183","author":"Wright","year":"2011","journal-title":"CMAJ"},{"issue":"9","key":"10.1016\/j.mcna.2014.11.005_bib41","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1345\/aph.1G293","article-title":"Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults","volume":"40","author":"Jacob","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.mcna.2014.11.005_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/JCP.0b013e31802e688a","article-title":"Duloxetine and hyponatremia: a report of 5 cases","volume":"27","author":"Kr\u00fcger","year":"2007","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.mcna.2014.11.005_bib43","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1176\/appi.neuropsych.12030070","article-title":"Venlafaxine-associated hyponatremia presenting with catatonia","volume":"25","author":"Grover","year":"2013","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.mcna.2014.11.005_bib44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.jcp.0000270086.22877.78","article-title":"Recurrent hyponatremia after substitution of citalopram with duloxetine","volume":"27","author":"Dirks","year":"2007","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.mcna.2014.11.005_bib45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cgh.2014.06.021","article-title":"Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis","volume":"13","author":"Jiang","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.mcna.2014.11.005_bib46","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ajg.2014.82","article-title":"Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis","volume":"109","author":"Anglin","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.mcna.2014.11.005_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1176\/appi.ajp.2013.12111467","article-title":"Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding","volume":"171","author":"Wang","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"7314","key":"10.1016\/j.mcna.2014.11.005_bib48","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.323.7314.655","article-title":"Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study","volume":"323","author":"van Walraven","year":"2001","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.mcna.2014.11.005_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/11531490-000000000-00000","article-title":"Safety considerations of fluoroquinolones in the elderly: an update","volume":"27","author":"Stahlmann","year":"2010","journal-title":"Drugs Aging"},{"issue":"12","key":"10.1016\/j.mcna.2014.11.005_bib50","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.amjmed.2012.05.027","article-title":"Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders","volume":"125","author":"Wise","year":"2012","journal-title":"Am J Med"},{"issue":"1429","key":"10.1016\/j.mcna.2014.11.005_bib51","first-page":"89","article-title":"Fluoroquinolones and peripheral neuropathy","volume":"55","year":"2013","journal-title":"Med Lett Drugs Ther"},{"issue":"12","key":"10.1016\/j.mcna.2014.11.005_bib52","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/archinternmed.2010.142","article-title":"Trimethoprim-sulfamethoxazole\u2013induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system","volume":"170","author":"Antoniou","year":"2010","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.mcna.2014.11.005_bib53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/106002809603000404","article-title":"Effect of standard-dose trimethoprim\/sulfamethoxazole on the serum potassium concentration in elderly men","volume":"30","author":"Witt","year":"1996","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.mcna.2014.11.005_bib54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cger.2012.01.006","article-title":"Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes","volume":"28","author":"Gnjidic","year":"2012","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.mcna.2014.11.005_bib55","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/ageing\/afm118","article-title":"(Screening tool to alert doctors to the right treatment)\u2013an evidence-based screening tool to detect prescribing omissions in elderly patients","volume":"36","author":"Barry","year":"2007","journal-title":"Age Ageing"},{"issue":"6","key":"10.1016\/j.mcna.2014.11.005_bib56","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/clpt.2011.44","article-title":"Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP\/START criteria","volume":"89","author":"Gallagher","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"16","key":"10.1016\/j.mcna.2014.11.005_bib57","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1056\/NEJMsa020703","article-title":"Adverse drug events in ambulatory care","volume":"348","author":"Gandhi","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2014.11.005_bib58","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/bmj.315.7115.1096","article-title":"Optimising drug treatment for elderly people: the prescribing cascade","volume":"315","author":"Rochon","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2014.11.005_bib59","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jamda.2013.02.021","article-title":"Medication reconciliation in continuum of care transitions: a moving target","volume":"14","author":"Sinvani","year":"2013","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"9","key":"10.1016\/j.mcna.2014.11.005_bib60","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1532-5415.2005.53523.x","article-title":"Unnecessary drug use in frail older people at hospital discharge","volume":"53","author":"Hajjar","year":"2005","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.mcna.2014.11.005_bib61","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/gps.3818","article-title":"Uncovering the source of new benzodiazepine prescriptions in community-dwelling older adults","volume":"28","author":"Halme","year":"2013","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"10.1016\/j.mcna.2014.11.005_bib62","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11096-006-9028-4","article-title":"Continuation of proton pump inhibitors from hospital to community","volume":"28","author":"Grant","year":"2006","journal-title":"Pharm World Sci"},{"issue":"19","key":"10.1016\/j.mcna.2014.11.005_bib63","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1001\/archinte.1997.00440400055007","article-title":"Adverse events after discontinuing medications in elderly outpatients","volume":"157","author":"Graves","year":"1997","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.mcna.2014.11.005_bib64","first-page":"430","article-title":"The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people","volume":"9","author":"Garfinkel","year":"2007","journal-title":"Isr Med Assoc J"},{"issue":"18","key":"10.1016\/j.mcna.2014.11.005_bib65","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1001\/archinternmed.2010.355","article-title":"Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy","volume":"170","author":"Garfinkel","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2014.11.005_bib66","doi-asserted-by":"crossref","first-page":"700","DOI":"10.7326\/0003-4819-157-10-201211200-00006","article-title":"Pharmacy dispensing of electronically discontinued medications","volume":"157","author":"Allen","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.mcna.2014.11.005_bib67","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/eb-2012-100930","article-title":"Deciding when to stop: towards evidence-based deprescribing of drugs in older populations","volume":"18","author":"Scott","year":"2013","journal-title":"Evid Based Med"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712514001953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712514001953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T01:44:23Z","timestamp":1566351863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712514001953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0025712514001953"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2014.11.005","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriate Prescribing and Important Drug Interactions in Older Adults","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2014.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}